- Report
- March 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- July 2025
- 368 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- July 2024
- 150 Pages
Global
From €2944EUR$3,250USD£2,538GBP
€4394EUR$4,850USD£3,787GBP
- Report
- May 2024
- 54 Pages
Global
From €2265EUR$2,500USD£1,952GBP
The Aortic Endograft market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to treat aortic aneurysms, a condition in which the aorta becomes weakened and enlarged. Endografts are inserted into the aorta through a catheter, and are designed to reduce the risk of rupture and provide long-term support. Endografts are typically made of a combination of fabric and metal, and are designed to be durable and flexible.
Endografts are used to treat a variety of aortic aneurysms, including thoracic, abdominal, and thoracoabdominal aneurysms. Endografts are also used to treat aortic dissections, a condition in which the inner layers of the aorta tear. Endografts are a minimally invasive alternative to open surgery, and can reduce recovery time and hospital stays.
The Aortic Endograft market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Medtronic, Cook Medical, W.L. Gore & Associates, and Endologix. Show Less Read more